Management of Pericardial Effusions/Tamponade in Cancer Patients

  • Sana Shoukat
  • Syed Wamique YusufEmail author
Reference work entry


Pericardial effusion is a common disorder among cancer population that is linked to survival. Echocardiogram and computed tomography (CT) are preferred modalities to assess the size of the effusion. In hemodynamically unstable patients with large pericardial effusions, emergent drainage is necessary. Several techniques for drainage are established, including surgery and percutaneous drainage.


Pericardial effusion Pericarditis Pericardiocentesis Tamponade 


  1. 1.
    Ning MS, Tang L, Gomez DR, et al. Incidence and predictors of pericardial effusion after chemoradiation therapy for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2017;99(1):70–9.CrossRefGoogle Scholar
  2. 2.
    Kim SH, Kwak MH, Park S, et al. Clinical characteristics of malignant pericardial effusion associated with recurrence and survival. Cancer Res Treat. 2010;42(4):210–6.CrossRefGoogle Scholar
  3. 3.
    Tsang TS, Seward JB, Barnes ME, et al. Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy. Mayo Clin Proc. 2000;75(3):248–53.CrossRefGoogle Scholar
  4. 4.
    Gornik HL, Gerhard-Herman M, Beckman JA. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol. 2005;23(22):5211–6.CrossRefGoogle Scholar
  5. 5.
    Jama GM, Scarci M, Bowden J, Marciniak SJ. Palliative treatment for symptomatic malignant pericardial effusion dagger. Interact Cardiovasc Thorac Surg. 2014;19(6):1019–26.CrossRefGoogle Scholar
  6. 6.
    Corey GR, Campbell PT, Van Trigt P, et al. Etiology of large pericardial effusions. Am J Med. 1993;95(2):209–13.CrossRefGoogle Scholar
  7. 7.
    Yusuf SW, Hassan SA, Mouhayar E, Negi SI, Banchs J, O’Gara PT. Pericardial disease: a clinical review. Expert Rev Cardiovasc Ther. 2016;14(4):525–39.CrossRefGoogle Scholar
  8. 8.
    Rodriguez ER, Tan CD. Structure and anatomy of the human pericardium. Prog Cardiovasc Dis. 2017;59(4):327–40.CrossRefGoogle Scholar
  9. 9.
    Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921–64.CrossRefGoogle Scholar
  10. 10.
    Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y. Controversial issues in the management of pericardial diseases. Circulation. 2010;121(7):916–28.CrossRefGoogle Scholar
  11. 11.
    Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet. 2004;363(9410):717–27.CrossRefGoogle Scholar
  12. 12.
    El Haddad D, Iliescu C, Yusuf SW, et al. Outcomes of cancer patients undergoing percutaneous pericardiocentesis for pericardial effusion. J Am Coll Cardiol. 2015;66(10):1119–28.CrossRefGoogle Scholar
  13. 13.
    Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J. 2013;34(16):1186–97.CrossRefGoogle Scholar
  14. 14.
    Sternbach G. Claude Beck: cardiac compression triads. J Emerg Med. 1988;6(5):417–9.CrossRefGoogle Scholar
  15. 15.
    Roy CL, Minor MA, Brookhart MA, Choudhry NK. Does this patient with a pericardial effusion have cardiac tamponade? JAMA. 2007;297(16):1810–8.CrossRefGoogle Scholar
  16. 16.
    Bilchick KC, Wise RA. Paradoxical physical findings described by Kussmaul: pulsus paradoxus and Kussmaul’s sign. Lancet. 2002;359(9321):1940–2.CrossRefGoogle Scholar
  17. 17.
    Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013;26(9):965–1012 e1015.CrossRefGoogle Scholar
  18. 18.
    Weitzman LB, Tinker WP, Kronzon I, Cohen ML, Glassman E, Spencer FC. The incidence and natural history of pericardial effusion after cardiac surgery – an echocardiographic study. Circulation. 1984;69(3):506–11.CrossRefGoogle Scholar
  19. 19.
    Argula RG, Negi SI, Banchs J, Yusuf SW. Role of a 12-lead electrocardiogram in the diagnosis of cardiac tamponade as diagnosed by transthoracic echocardiography in patients with malignant pericardial effusion. Clin Cardiol. 2015;38(3):139–44.CrossRefGoogle Scholar
  20. 20.
    Saab J, Hoda RS, Narula N, et al. Diagnostic yield of cytopathology in evaluating pericardial effusions: clinicopathologic analysis of 419 specimens. Cancer Cytopathol. 2017;125(2):128–37.CrossRefGoogle Scholar
  21. 21.
    Langdon SE, Seery K, Kulik A. Contemporary outcomes after pericardial window surgery: impact of operative technique. J Cardiothorac Surg. 2016;11(1):73.CrossRefGoogle Scholar
  22. 22.
    Maggiolini S, Gentile G, Farina A, et al. Safety, efficacy, and complications of pericardiocentesis by real-time echo-monitored procedure. Am J Cardiol. 2016;117(8):1369–74.CrossRefGoogle Scholar
  23. 23.
    Patel N, Rafique AM, Eshaghian S, et al. Retrospective comparison of outcomes, diagnostic value, and complications of percutaneous prolonged drainage versus surgical pericardiotomy of pericardial effusion associated with malignancy. Am J Cardiol. 2013;112(8):1235–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of CardiologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations